123 related articles for article (PubMed ID: 35655115)
1. [
Herrera-Martínez Y; Vercher-Conejero JL; Martín-Marcuartu JJ; Telué Vega A; Guerrero-Pérez F; Cortés Romera M
J Nucl Cardiol; 2023 Aug; 30(4):1706-1708. PubMed ID: 35655115
[No Abstract] [Full Text] [Related]
2. Thyroid metastasis from lung carcinoid detected by
Albano D; Giubbini R; Bertagna F
Endocrine; 2021 Oct; 74(1):202-203. PubMed ID: 33821389
[No Abstract] [Full Text] [Related]
3. Serous cystadenoma mimicking cystic pancreatic neuroendocrine tumor on
Passand GT; Marichez A; Debordeaux F; Pinaquy JB; Chiche L
Diagn Interv Imaging; 2022 Nov; 103(11):563-565. PubMed ID: 36280584
[No Abstract] [Full Text] [Related]
4. Clinical significance of atypical
Gossili F; Almasi CE; Zacho HD
Hell J Nucl Med; 2023; 26(2):94-98. PubMed ID: 37527044
[TBL] [Abstract][Full Text] [Related]
5. Cervical Ganglioneuroblastoma Diagnosed by
Al-Muqbel K; Alardah H; Al-Smadi R; Al-Khatib S; Abughanmi R
J Nucl Med Technol; 2023 Dec; 51(4):337-338. PubMed ID: 37586852
[TBL] [Abstract][Full Text] [Related]
6.
Ouvrard E; Mestier L; Boursier C; Lachachi B; Sahakian N; Chevalier E; Mikail N; Carullo J; Bando-Delaunay A; Walter T; Malouf GG; Addeo P; Poncet G; Sebag F; Lebtahi R; Goichot B; Taïeb D; Imperiale A
J Nucl Med; 2022 Dec; 63(12):1865-1870. PubMed ID: 35589408
[TBL] [Abstract][Full Text] [Related]
7. Fibromatosis mimicking relapse of a neuroendocrine tumor at 68Ga-DOTATOC positron-emission tomography/computed tomography.
Trevisi E; Facilissimo I; Taraglio S; Brizzi MP
J Cancer Res Ther; 2022; 18(4):1171-1173. PubMed ID: 36149180
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of
Sawicki LM; Deuschl C; Beiderwellen K; Ruhlmann V; Poeppel TD; Heusch P; Lahner H; Führer D; Bockisch A; Herrmann K; Forsting M; Antoch G; Umutlu L
Eur Radiol; 2017 Oct; 27(10):4091-4099. PubMed ID: 28439648
[TBL] [Abstract][Full Text] [Related]
9. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
[TBL] [Abstract][Full Text] [Related]
10.
Bélissant Benesty O; Nataf V; Ohnona J; Michaud L; Zhang-Yin J; Bertherat J; Chanson P; Reznik Y; Talbot JN; Montravers F
Endocrine; 2020 Mar; 67(3):708-717. PubMed ID: 31583575
[TBL] [Abstract][Full Text] [Related]
11. Intraindividual comparison of
Ouvrard E; Chevalier E; Addeo P; Sahakian N; Detour J; Goichot B; Bachellier P; Karcher G; Taïeb D; Imperiale A
Clin Endocrinol (Oxf); 2021 Jan; 94(1):66-73. PubMed ID: 32790887
[TBL] [Abstract][Full Text] [Related]
12. Assessment of a well-differentiated pancreatic neuroendocrine tumor with
Prado-Wohlwend S; Ballesta-Moratalla M; Torres-Espallardo I; Del Olmo-García MI; Sánchez-Vañó R; Bello-Arques P
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(4):259-260. PubMed ID: 34218892
[No Abstract] [Full Text] [Related]
13. Additional information gained by positron emission tomography with (68)Ga-DOTATOC for suspected unknown primary or recurrent neuroendocrine tumors.
Nakamoto Y; Sano K; Ishimori T; Ueda M; Temma T; Saji H; Togashi K
Ann Nucl Med; 2015 Jul; 29(6):512-8. PubMed ID: 25894056
[TBL] [Abstract][Full Text] [Related]
14. Role of (68)Ga-DOTATOC PET/CT in the evaluation of primary pulmonary carcinoids.
Jindal T; Kumar A; Venkitaraman B; Dutta R; Kumar R
Korean J Intern Med; 2010 Dec; 25(4):386-91. PubMed ID: 21179276
[TBL] [Abstract][Full Text] [Related]
15. The role of
Lococo F; Rapicetta C; Filice A; Mengoli MC; Ricchetti T; Borrelli R; Paci M
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):257-258. PubMed ID: 29636234
[No Abstract] [Full Text] [Related]
16. Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.
Van Binnebeek S; Vanbilloen B; Baete K; Terwinghe C; Koole M; Mottaghy FM; Clement PM; Mortelmans L; Bogaerts K; Haustermans K; Nackaerts K; Van Cutsem E; Verslype C; Verbruggen A; Deroose CM
Eur Radiol; 2016 Mar; 26(3):900-9. PubMed ID: 26162577
[TBL] [Abstract][Full Text] [Related]
17. Value of
Imperiale A; Boursier C; Sahakian N; Ouvrard E; Chevalier E; Sebag F; Addeo P; Taïeb D
J Nucl Med; 2022 Mar; 63(3):384-388. PubMed ID: 34272321
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
20. Prospective Within-Patient Assessment of the Impact of an Unlabeled Octreotide Pre-dose on the Biodistribution and Tumor Uptake of
Lodge MA; Solnes LB; Chaudhry MA; Wahl RL
Mol Imaging Biol; 2021 Oct; 23(5):766-774. PubMed ID: 33829361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
